REC0559-B-001 (RECORDATI Rare Disease)

Status

Open, enrolling

Results

Link goes here

Purpose

To test the efficacy, safety, and pharmacokinetics of 3 doses of REC0/0559 eye drops for the treatment of stage 2 (moderate) and stage 3 (severe) Neurotrophic keratitis in adults patients.